Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Levy (Boston, United States of America). Resolution of inflammation in airway diseases. Annual Congress 2005 - Mechanisms of resolution of inflammation

Member's Comments

No comment yet.

Related content which might interest you: Endogenous lipid mediators in the resolution of airway inflammation Source: Eur Respir J 2007; 30: 980-992 Year: 2007 An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 The clinical importance of measuring airway inflammation Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management Year: 2005 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Source: Eur Respir J 2008; 31: 1334-1356 Year: 2008 Neurokinins contribute to vascular remodelling in a model of chronic pulmonary allergic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 760s Year: 2006 Bronchial inflammatory changes in wheezy infants Source: Annual Congress 2007 - Bronchial inflammation in wheezing infants and pre-school children Year: 2007 PAH and inflammation: its role in pathogenesis - is it of value to modulate it? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD Source: Annual Congress 2005 - Protease-antiprotease revisited Year: 2005 The role of inflammation in COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Cigarette smoke-induced pulmonary inflammation, but not airway wall remodeling, is attenuated in CCR5 deficient mice Source: Annual Congress 2007 - The best of airway epithelial cells Year: 2007 COPD: inflammatory mechanisms and systemic consequences Source: Eur Respir Mon 2013; 59: 13-27 Year: 2013 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Are we ready to monitor inflammation and remodelling in asthma? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Neomacrolides in airway disease Source: Annual Congress 2005 - New developments in infectious disease Year: 2005